As GLP-1 medications normalize smaller appetites and higher protein intake, national restaurant chains are quietly ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Some of the most significant changes include what GLP-1 users eat at restaurants. Technomic data shows that one-third of users order healthier foods, while the top five menu items they avoid include ...

Conagra Brands added a “GLP-1 Friendly” label to 26 of its Healthy Choice frozen meals in early 2025. The Smoothie King chain ...

Structure Therapeutics CEO Ray Stevens talked about the biotech’s path forward and his expectations for the future of the ...

As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...

Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...

Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s ...

Diabetes care is undergoing a major transformation driven by GLP-1 receptor agonists, which have expanded beyond glycemic ...